Literature DB >> 28422320

miR-34b Modulates Skeletal Muscle Cell Proliferation and Differentiation.

Zhixiong Tang1, Huiling Qiu1,2, Lan Luo1, Nian Liu1, Jiasheng Zhong1, Kang Kang3, Deming Gou1.   

Abstract

Myogenesis involves myoblast proliferation and differentiation to myocytes, followed by fusion and hypertrophy to form myotubes during muscle development. Increasing evidence showed that microRNAs (miRNAs) play important roles in the regulation of myogenesis. We have previously revealed that miR-34b is steadily increased during this process. This miRNA regulates differentiation in various cell types, though its function in myogenesis remains to be elucidated. In this study, we show that miR-34b represses muscle cell proliferation and promotes myotube formation. Our quantitative iTRAQ-based proteomic analysis reveals 97 proteins are regulated by miR-34b in mouse myoblast C2C12. We identified that miR-34b targets 14-3-3 protein gamma, adenosylhomocysteinase and nucleolin by binding to their 3'UTR. Further analysis of these proteins expression patterns show that nucleolin is a cognate target of miR-34b during myogenic differentiation. Here, we proved that a moderate reduction of nucleolin in cells enhanced the myotube formation. However, nucleolin is required for myogenesis, as cells with low levels of nucleolin reduced cell proliferation rate and are unable to differentiate. Our data demonstrated that nucleolin regulates myogenesis in a protein-abundance-dependent manner. J. Cell. Biochem. 118: 4285-4295, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  MYOGENIC DIFFERENTIATION; NUCLEOLIN; PROLIFERATION; SKELETAL MUSCLE; miR-34b

Mesh:

Substances:

Year:  2017        PMID: 28422320     DOI: 10.1002/jcb.26079

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus.

Authors:  Shunichi Nakamura; Shinichi Yonekura; Takeshi Shimosato; Tomohide Takaya
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

2.  MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.

Authors:  Xin Zhao; Zhigang Ji; Yi Xie; Guanghua Liu; Hanzhong Li
Journal:  Oncol Rep       Date:  2017-09-25       Impact factor: 3.906

3.  A transcriptomic study of myogenic differentiation under the overexpression of PPARγ by RNA-Seq.

Authors:  Kan He; Guoying Wu; Wen-Xing Li; Daogang Guan; Wenwen Lv; Mengting Gong; Shoudong Ye; Aiping Lu
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

Review 4.  Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties.

Authors:  Vincenzo Giancotti; Natascha Bergamin; Palmina Cataldi; Claudio Rizzi
Journal:  Int J Cell Biol       Date:  2018-04-24

5.  MiR-34b-5p Mediates the Proliferation and Differentiation of Myoblasts by Targeting IGFBP2.

Authors:  Zhijun Wang; Xiaocui Zhang; Zhenhui Li; Bahareldin Ali Abdalla; Yangfeng Chen; Qinghua Nie
Journal:  Cells       Date:  2019-04-17       Impact factor: 6.600

6.  Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin.

Authors:  Sayaka Shinji; Koji Umezawa; Yuma Nihashi; Shunichi Nakamura; Takeshi Shimosato; Tomohide Takaya
Journal:  Front Cell Dev Biol       Date:  2021-01-11

7.  MiR-22-3p Inhibits Proliferation and Promotes Differentiation of Skeletal Muscle Cells by Targeting IGFBP3 in Hu Sheep.

Authors:  Shan Wang; Xiukai Cao; Ling Ge; Yifei Gu; Xiaoyang Lv; Tesfaye Getachew; Joram M Mwacharo; Aynalem Haile; Wei Sun
Journal:  Animals (Basel)       Date:  2022-01-04       Impact factor: 2.752

8.  Chromatin accessibility is associated with the changed expression of miRNAs that target members of the Hippo pathway during myoblast differentiation.

Authors:  Huanhuan Zhou; Yue Xiang; Mingyang Hu; Yueyuan Xu; Ye Hou; Xiaolong Qi; Liangliang Fu; Yu Luan; Zhangxu Wang; Xinyun Li; Yunxia Zhao; Shuhong Zhao
Journal:  Cell Death Dis       Date:  2020-02-24       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.